跳至主要内容
临床试验/IRCT20220928056051N2
IRCT20220928056051N2尚未招募3 期

Assessment of the N-Acetyl cysteine effect on therapeutic outcome of diabetic foot ulcers

Oroumia University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age above 18 years
  • Grade 3 or 4 diabetic foot ulcer according to Wagner criteria

排除标准

  • Allergy to N-Acetyl cysteine and sulfur products
  • Pregnancy and breastfeeding
  • Other causes of ulcers except diabetes include trauma and others
  • A generated- ulcers skin disease
  • Impossibility of taking tablets orally
  • Patients treated with chemotherapy or radiotherapy drugs
  • Taking drugs such as: corticosteroids at a minimum dose equivalent to 40 milligrams of prednisolone, mycophenolate, cyclosporine, tacrolimus, rituximab
  • Hospitalized for a diabetic foot ulcer in the last month and receiving injection antibiotic treatment
  • Stenosis and severe cramping of the lower limbs vessels based on vascular sonography
  • Chronic alcohol consumption of more than 250 cc daily

研究者

发起方
Oroumia University of Medical Sciences

相似试验

Assessment of the N-Acetyl cysteine effect on... | 临床试验